Company Filing History:
Years Active: 2009
Title: The Innovations of Elliot Katten
Introduction
Elliot Katten is an accomplished inventor based in Flushing, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on prodrugs.
Latest Patents
Elliot Katten holds a patent for "Dihydrothiazine prodrugs of thiazolium agents." This patent includes compounds that can be converted under acidic conditions to thiazolium agents. The compounds are designed for administration to mammals, including humans, for the treatment of various medical indications. His work in this area has the potential to enhance therapeutic options in the pharmaceutical industry.
Career Highlights
Katten is associated with Synvista Therapeutics, Inc., where he continues to develop and refine his innovative ideas. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the research and development of new therapeutic agents.
Collaborations
Elliot Katten collaborates with Emily J Reinhard, contributing to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Elliot Katten's work exemplifies the impact of innovation in the pharmaceutical field, showcasing how his patents can lead to significant advancements in treatment options. His contributions are a testament to the importance of research and collaboration in driving medical progress.